Physicians’ gender and specialty in relation to adverse drug reaction reporting in Sweden
European Journal of Clinical Pharmacology · 2026-06 · 82 (6)
DOI: 10.1007/s00228-026-04077-9 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 08.05.2026. Verfasst von Lina-Maria Nordvall und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Translational Biology, Clinical Pharmacology and Pharmacology, Umeå University, Umeå, Sweden. lina-maria.nordvall@umu.se. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Medicine, Physicians, Sex Factors. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umea University.
Abstract (Originalsprache)
Purpose
To evaluate the possible influence of gender and specialty on adverse drug reaction (ADR) reporting among physicians before and after the COVID-19 pandemic.
Methods
This retrospective nationwide register study analysed all ADR reports submitted by physicians to the Swedish Medical Products Agency during 2017 and 2023 ( n = 4079 and 3740, respectively). The reporting rates were calculated and stratified by gender and specialty.
Results
The highest reporting rate among physicians was observed in medical specialties, followed by primary care and psychiatry (27, 10, and 12, reports/100 physicians in 2017; 18, 15, and 9 in 2023). The lowest reporting rates were observed for surgical and hospital service specialties (8 and 1 in 2017; 6 and 1 in 2023). Male and female physicians reported ADRs to a similar extent and both reported more frequently on female patients. Gender concordance between physician and patient was associated with significantly higher reporting ( p < 0.001 in 2017; p = 0.041 in 2023).
Conclusion
Reporting varied across specialties, and gender concordance emerged as a previously unrecognized factor influencing ADR reporting. These findings provide new opportunities for targeted interventions to enhance physician participation in pharmacovigilance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Translational Biology, Clinical Pharmacology and Pharmacology, Umeå University, Umeå, Sweden. lina-maria.nordvall@umu.se.
- Futurum-Academy for Healthcare, Jönköping, Sweden.
- Medical Products Agency, Uppsala, Sweden.
- Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
- Department of Medical and Translational Biology, Clinical Pharmacology and Pharmacology, Umeå University, Umeå, Sweden.
- Department of Clinical Science, Child and Adolescent Psychiatry, Umeå University, Umeå, Sweden.
Förderung
- Umea University
Zitieren
APA
Nordvall, L. M., Rolander, B., Larsson, M., Melin, L., Hägg, S., & Kling, A. (2026). Physicians’ gender and specialty in relation to adverse drug reaction reporting in Sweden. European Journal of Clinical Pharmacology, 82(6). https://doi.org/10.1007/s00228-026-04077-9
Vancouver
Nordvall LM, Rolander B, Larsson M, Melin L, Hägg S, Kling A. Physicians’ gender and specialty in relation to adverse drug reaction reporting in Sweden. European Journal of Clinical Pharmacology. 2026;82(6). doi:10.1007/s00228-026-04077-9
BibTeX
@article{Nordvall2026,
author = {Nordvall, Lina-Maria and Rolander, Bo and Larsson, Maria and Melin, Linnea and Hägg, Staffan and Kling, Anders},
title = {Physicians’ gender and specialty in relation to adverse drug reaction reporting in Sweden},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {6},
doi = {10.1007/s00228-026-04077-9}
}
EUVIMED